Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates and calculations
1.3 Forecast calculations
1.4 Data sources
1.4.1 Secondary
1.4.1.1 Paid sources
1.4.1.2 Public sources
1.4.2 Primary
Chapter 2 Executive Summary
2.1 Encephalitis treatment industry 3600 synopsis, 2018 – 2032 (USD Billion)
2.1.1 Business trends
2.1.2 Region trends
2.1.3 Disease type trends
2.1.4 Treatment trends
2.1.5 Route of administration
2.1.6 End-user trends
Chapter 3 Encephalitis Market Insights
3.1 Industry landscape, 2018 – 2032 (USD Billion)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of encephalitis
3.2.1.2 Increase in awareness about treatment for encephalitis
3.2.1.3 Increasing investment in R&D by pharmaceutical companies
3.2.1.4 Increase in government initiatives for encephalitis disease diagnosis and treatment
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with the treatment
3.3 Growth potential analysis
3.3.1 By disease type
3.3.2 By treatment
3.3.3 By route of administration
3.3.4 By end-user
3.4 COVID-19 impact analysis
3.5 Clinical trial analysis
3.6 Regulatory landscape
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022
Chapter 5 Encephalitis Treatment Market Estimates and Forecast, By Disease Type (USD Billion)
5.1 Key trends, by disease type
5.2 Primary encephalitis
5.3 Secondary encephalitis
Chapter 6 Encephalitis Treatment Market Estimates and Forecast, By Treatment (USD Billion)
6.1 Key trends, by treatment
6.2 Antiviral agents
6.3 Steroid injections
6.4 Antibiotics
6.5 Immunoglobulin therapy
6.6 Plasmapheresis
6.7 Other treatments
Chapter 7 Encephalitis Treatment Market Estimates and Forecast, By Route of Administration (USD Billion)
7.1 Key trends, by route of administration
7.2 Oral
7.3 Parenteral
7.4 Other routes of administration
Chapter 8 Encephalitis Treatment Market Estimates and Forecast, By End-user (USD Billion)
8.1 Key trends, by end-user
8.2 Hospitals
8.3 Specialty clinics
8.4 Other end-users
Chapter 9 Encephalitis Treatment Market Estimates and Forecast, By Region (USD Billion)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Switzerland
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Pfizer, Inc.
10.2 Merck & Co., Inc.
10.3 Allergan
10.4 GlaxoSmithKline plc
10.5 Abbott Laboratories
10.6 F. Hoffmann-La Roche Ltd.
10.7 Sanofi
10.8 Teva Pharmaceutical Industries Ltd.
10.9 Basilea Pharmaceutical Ltd.
10.10 Melinta Therapeutics LLC.
